Clinical, MRI, and PET-CT criteria used by surgeons to determine suitability for pelvic exenteration surgery for recurrent rectal cancers: A delphi study

Diseases of the Colon and Rectum

Volumn 56, Issue 6, 2013, Pages 717-725

  Chew, Min Hoe ^a,b   Brown, Wendy E ^a   Masya, Lindy ^a,b   Harrison, James D ^b   Myers, Eddie ^a   Solomon, Michael J ^a,b,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Magnetic resonance imaging; Pelvic exenteration; Positron emission tomography; Recurrent rectal cancer

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONSENSUS; CONTROLLED STUDY; DELPHI STUDY; EVISCERATION; FEMALE; HUMAN; LONG TERM SURVIVAL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS EXENTERATION; POSITRON EMISSION TOMOGRAPHY; RECTUM CANCER; RECURRENT CANCER; SURGEON;

DELPHI TECHNIQUE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PELVIC EXENTERATION; PHYSICIANS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; QUESTIONNAIRES; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 84879122808     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e3182812bec     Document Type: Article

References (40)

1. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma: a one-stage abdominoperinal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1948;1:177-183.
2. Heriot AG, Byrne CM, Lee P, et al. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum. 2008;51:284-291.
3. Austin KK, Young JM, Solomon MJ. Quality of life of survivors after pelvic exenteration for rectal cancer. Dis Colon Rectum. 2010;53:1121-1126.
4. Jimenez RE, Shoup M, Cohen AM, Paty PB, Guillem J, Wong WD. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer. Dis Colon Rectum. 2003;46:1619-1625.
5. Ike H, Shimada H, Yamaguchi S, Ichikawa Y, Fujii S, Ohki S. Outcome of total pelvic exenteration for primary rectal cancer. Dis Colon Rectum. 2003;46:474-480.
6. Vermaas M, Ferenschild FT, Verhoef C, et al. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol. 2007;33:452-458.
7. F erenschild FT, Vermaas M, Verhoef C, et al. Total pelvic exenteration for primary and recurrent malignancies. World J Surg. 2009;33:1502-1508.
8. Nielsen M, Rasmussen P, Lindegaard J, Laurberg S. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database. Colorectal Dis 2012;14:1076-1083.
9. Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg. 2003;237:502-508.
10. Heriot AG, Tekkis PP, Darzi A, Mackay J. Surgery for local recurrence of rectal cancer. Colorectal Dis. 2006;8:733-747.
11. Messiou C, Chalmers AG, Boyle K, Wilson D, Sagar P. Pre-operative MR assessment of recurrent rectal cancer. Br J Radiol. 2008;81:468-473.
12. Dresen RC, Kusters M, Daniels-Gooszen AW, et al. Absence of tumor invasion into pelvic structures in locally recurrent rectal cancer: prediction with preoperative MR imaging. Radiology. 2010;256:143-150.
13. Schaefer O, Langer M. Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol. 2007;17:2044-2054.
14. Fukunaga H, Sekimoto M, Ikeda M, et al. Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer. Ann Surg Oncol. 2005;12:561-569.
15. Huebner RH, Park KC, Shepherd JE, et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med. 2000;41:1177-1189.
16. Glimelius B, Påhlman L, Cervantes A; ESMO Guidelines Working Group. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl 5):v82-v86.
17. Tjandra JJ, Kilkenny JW, Buie WD, et al; Standards Practice Task Force; American Society of Colon and Rectal Surgeons. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2005;48:411-423.
18. Engstrom PF, Arnoletti JP, Benson AB 3rd, et al National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw. 2009;7:838-881.
19. Goodman, L.A. "Snowball sampling." Ann Math Stat 1961;32: 148-170.
20. Linstone H.A, Turoff M. The Delphi Method: Techniques and Application. Boston, MA: Addison-Wesley Publishing Co, Advanced Book Program: 2002.
21. Mirnezami AH, Sagar PM, Kavanagh D, Witherspoon P, Lee P, Winter D. Clinical algorithms for the surgical management of locally recurrent rectal cancer. Dis Colon Rectum. 2010;53:1248-1257.
22. Lopez MJ, Standiford SB, Skibba JL. Total pelvic exenteration. A 50-year experience at the Ellis Fischel Cancer Center. Arch Surg. 1994;129:390-395.
23. Moore HG, Shoup M, Riedel E, et al. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum. 2004;47:1599-1606.
24. Moriya Y, Akasu T, Fujita S, Yamamoto S. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum. 2004;47:2047-2053.
25. Nakafusa Y, Tanaka T, Tanaka M, Kitajima Y, Sato S, Miyazaki K. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Colon Rectum. 2004;47:2055-2063.
26. Pacelli F, Tortorelli AP, Rosa F, et al. Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy. Ann Surg Oncol. 2010;17:152-162.
27. Quinten C, Coens C, Mauer M, et al EORTC Clinical Groups. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. 2009;10:865-871.
28. You YN, Habiba H, Chang GJ, Rodriguez-bigas MA, Skibber JM. Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2011;18:989-996.
29. Gagliardi G, Hawley PR, Hershman MJ, Arnott SJ. Prognostic factors in surgery for local recurrence of rectal cancer. Br J Surg. 1995;82:1401-1405.
30. Hartley JE, Lopez RA, Paty PB, Wong WD, Cohen AM, Guillem JG. Resection of locally recurrent colorectal cancer in the presence of distant metastases: can it be justified? Ann Surg Oncol. 2003;10:227-233.
31. Beets-Tan RG, Beets GL, Borstlap AC, et al. Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI? Abdom Imaging. 2000;25:533-541.
32. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet. 2001;357:497-504.
33. Guillem JRL. Strategies in operative therapy for locally recurrent rectal cancer. Semin Colon Rectal Surg 1998;9:259-268.
34. Boyle KM, Sagar PM, Chalmers AG, Sebag-Montefiore D, Cairns A, Eardley I. Surgery for locally recurrent rectal cancer. Dis Colon Rectum. 2005;48:929-937.
35. Yamada K, Ishizawa T, Niwa K, Chuman Y, Akiba S, Aikou T. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg. 2001;88: 988-993.
36. Suzuki K, Dozois RR, Devine RM, et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum. 1996;39:730-736.
37. Wanebo HJ, Antoniuk P, Koness RJ, et al. Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum. 1999;42:1438-1448.
38. Lopez MJ, Luna-Pérez P. Composite pelvic exenteration: is it worthwhile? Ann Surg Oncol. 2004;11:27-33.
39. Melton GB, Paty PB, Boland PJ, et al. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum. 2006;49:1099-1107.
40. Austin KK, Solomon MJ. Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement. Dis Colon Rectum. 2009;52:1223-1233.